Researchers at Harvard University and affiliated institutions developed a new, easy-to-use, web-based tool that simplifies ...
Timely next-generation sequencing testing in patients with metastatic prostate cancer: A comparative analysis between Medicare Advantage and traditional Medicare. This is an ASCO Meeting Abstract from ...
Experts discuss the necessity of ESR1 mutation testing when considering treatment with elacestrant in patients with estrogen receptor–positive (ER+)/HER2-negative (HER2–) metastatic breast cancer and ...
About 5 to 10% of breast cancer cases are linked to inherited gene mutations, which is why doctors recommend all women ...
Many people who underwent BRCA genetic testing more than 13 years ago may carry an undetected mutation linked to higher ...
Scientists at the Victor Chang Cardiac Research Institute, working with colleagues at the Vanderbilt University Medical Center, have developed a world-first, individualized risk prediction tool for ...
Genetic testing can confirm a muscular dystrophy (MD) diagnosis when symptoms and other tests already suggest MD. It also identifies specific gene mutations that can guide targeted treatment. Genetic ...
Eleven years after my mother died in 1994, when I was 31, I learned that a simple blood test could confirm whether I was a carrier of a BRCA gene mutation. Named for the first two letters of "breast" ...
Inheriting a mutation in BRCA1 or BRCA2 puts you at higher risk of breast, prostate, ovarian and pancreatic cancer. Genetic testing and screening can be life-saving.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results